CLINICAL_TRIALS
trial_result
· 2025-03-10
Clinical Trial Update: Arabinoxylan-oligosaccharides (AXOS) for the Management of Type-2 Diabetes [NA]
Summary
A clinical trial sponsored by Lund University evaluating arabinoxylan-oligosaccharides (AXOS) for the management of type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lund University | Conditions: Diabetes Type 2 | NA | Status: COMPLETED